146 related articles for article (PubMed ID: 38741816)
1. Metastasectomy and Stereotactic Body Radiotherapy for Colorectal Cancer With Liver and Lung Oligometastases: A Case Report of Complete Remission in a 96-Year-Old Patient.
Pan M
Cureus; 2024 Apr; 16(4):e58135. PubMed ID: 38741816
[TBL] [Abstract][Full Text] [Related]
2. Abscopal Resolution of a Hepatic Metastasis in a Patient with Metastatic Cholangiocarcinoma Following Radical Stereotactic Body Radiotherapy to a Synchronous Early Stage Non-small Cell Lung Cancer.
Kim JO; Kim CA
Cureus; 2019 Feb; 11(2):e4082. PubMed ID: 31019860
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
Front Oncol; 2019; 9():1080. PubMed ID: 31681609
[No Abstract] [Full Text] [Related]
4. Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report.
Alnsour A; Le H; Byrne A; Rodgers N; Roos D
J Med Case Rep; 2023 Jun; 17(1):273. PubMed ID: 37312213
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy (SBRT) for Liver Oligometastases: Outcomes and Safety.
Cazic D; Marosevic G
Acta Med Acad; 2020 Dec; 49(3):225-231. PubMed ID: 33781065
[TBL] [Abstract][Full Text] [Related]
8. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
Takeda A; Sanuki N; Tsurugai Y; Oku Y; Aoki Y
J Radiat Res; 2016 Jul; 57(4):400-5. PubMed ID: 26983981
[TBL] [Abstract][Full Text] [Related]
10. Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
Benson KRK; Sandhu N; Zhang C; Ko R; Toesca DAS; Lee PE; Von Eyben R; Diehn M; Gensheimer M; Maxim PG; Bush K; Loo BW; Soltys SG; Pollom EL; Chang DT
Am J Clin Oncol; 2021 Nov; 44(11):559-564. PubMed ID: 34534143
[TBL] [Abstract][Full Text] [Related]
11. Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.
Kirste S; Kayser G; Zipfel A; Grosu AL; Brunner T
Radiat Oncol; 2018 Feb; 13(1):28. PubMed ID: 29463266
[TBL] [Abstract][Full Text] [Related]
12. Safety of Stereotactic Body Radiation Therapy for Seven Ipsilateral Lung Lesions.
Bernard ME; Critchfield L; Kudrimoti M
Cureus; 2020 Jun; 12(6):e8759. PubMed ID: 32714697
[TBL] [Abstract][Full Text] [Related]
13. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
[TBL] [Abstract][Full Text] [Related]
14. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.
Teh BS; Paulino AC; Lu HH; Chiu JK; Richardson S; Chiang S; Amato R; Butler EB; Bloch C
Technol Cancer Res Treat; 2007 Aug; 6(4):347-54. PubMed ID: 17668943
[TBL] [Abstract][Full Text] [Related]
18. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by
Mazzola R; Fiorentino A; Di Paola G; Giaj Levra N; Ricchetti F; Fersino S; Tebano U; Pasetto S; Ruggieri R; Salgarello M; Alongi F
J Thorac Oncol; 2017 Mar; 12(3):547-555. PubMed ID: 28126325
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiotherapy versus Surgery for Lung Metastases from Colorectal Cancer: Single-Institution Results.
Garcia-Exposito N; Ramos R; Navarro-Perez V; Molina K; Arnaiz MD; Padrones S; Ruffinelli JC; Santos C; Guedea F; Navarro-Martin A
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
